Literature DB >> 2858237

Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex.

N L Harrison, M A Simmonds.   

Abstract

Coronal sections of rat brain (500 micron thick) were trimmed to form 'wedges' of tissue consisting of cerebral cortex and corpus callosum. When these slices were placed in a two-compartment bath, the cortical tissue could be depolarized, relative to the corpus callosum, by superfusions of high K+, or by amino acids such as L-glutamate, L-aspartate, quisqualate, kainate and N-methyl D-aspartate (NMDA). Responses to NMDA were reduced by magnesium ions, by the organic antagonists (-)-2-amino 5-phosphonovalerate (APV) and 2-amino 7-phosphonoheptanoate (APH), and by the dissociative anaesthetic ketamine. In this preparation, all these antagonists shifted the NMDA dose-response curve to the right in a parallel manner. A Schild plot for Mg2+ had a slope significantly less than unity, indicative of a non-competitive action, whilst Schild plots for (-)-APV, APH and ketamine appeared linear and had slopes of approximately 1. Analysis of the results of combination experiments suggested that the presumed competitive antagonists, (-)-APV and APH, share a common site of action as NMDA antagonists, and that this site is distinct from that at which ketamine exerts its action. The action of Mg2+ is clearly different from that of either (-)-APV or ketamine. It is concluded that ketamine is a non-competitive antagonist of NMDA and may act at an allosteric site on the NMDA receptor complex to influence its function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858237      PMCID: PMC1987274          DOI: 10.1111/j.1476-5381.1985.tb12922.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

Review 1.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

2.  Modification of dose-response curves by effector blockade and uncompetitive antagonism.

Authors:  P Pennefather; D M Quastel
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

3.  Classification of some GABA antagonists with regard to site of action and potency in slices of rat cuneate nucleus.

Authors:  M A Simmonds
Journal:  Eur J Pharmacol       Date:  1982-06-04       Impact factor: 4.432

4.  Anticonvulsant action of excitatory amino acid antagonists.

Authors:  M J Croucher; J F Collins; B S Meldrum
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

5.  The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations.

Authors:  R H Evans; A A Francis; A W Jones; D A Smith; J C Watkins
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

6.  THE EXCITATION AND DEPRESSION OF MAMMALIAN CORTICAL NEURONES BY AMINO ACIDS.

Authors:  J M CRAWFORD; D R CURTIS
Journal:  Br J Pharmacol Chemother       Date:  1964-10

7.  Presynaptic actions of gamma-aminobutyric acid and some antagonists in a slice preparation of cuneate nucleus.

Authors:  M A Simmonds
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

8.  Blockade of amino acid-induced depolarizations and inhibition of excitatory post-synaptic potentials in rat dentate gyrus.

Authors:  V Crunelli; S Forda; J S Kelly
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

9.  The antagonism of amino acid-induced excitations of rat hippocampal CA1 neurones in vitro.

Authors:  G L Collingridge; S J Kehl; H McLennan
Journal:  J Physiol       Date:  1983-01       Impact factor: 5.182

10.  The role of the electrogenic sodium pump in the glutamate afterhyperpolarization of frog spinal cord.

Authors:  A L Padjen; P A Smith
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

View more
  103 in total

1.  5-hydroxyindole causes convulsions and increases transmitter release in the CA1 region of the rat hippocampus.

Authors:  Guido Mannaioni; Raffaella Carpenedo; Flavio Moroni
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

2.  Behavioral characterization of knockin mice with mutations M287L and Q266I in the glycine receptor α1 subunit.

Authors:  Yuri A Blednov; Jill M Benavidez; Gregg E Homanics; R Adron Harris
Journal:  J Pharmacol Exp Ther       Date:  2011-10-28       Impact factor: 4.030

Review 3.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

Review 4.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

5.  The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli.

Authors:  P M Headley; C G Parsons; D C West
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

6.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Abutaher M Yahia; Jawad F Kirmani; Adnan I Qureshi; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats.

Authors:  L A Marco; R S Joshi; R B Chronister
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.

Authors:  K M Coates; P Flood
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

Authors:  L Turski; A Huth; M Sheardown; F McDonald; R Neuhaus; H H Schneider; U Dirnagl; F Wiegand; P Jacobsen; E Ottow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid.

Authors:  F Moroni; A Galli; G Mannaioni; V Carla; A Cozzi; F Mori; M Marinozzi; R Pellicciari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.